{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:14:44Z","timestamp":1792710884724,"version":"4.5.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To detect targeted antileukemia agents we have designed a novel, high-content in vivo screen using genetically engineered, T-cell reporting zebrafish. We exploited the developmental similarities between normal and malignant T lymphoblasts to screen a small molecule library for activity against immature T cells with a simple visual readout in zebrafish larvae. After screening 26 400 molecules, we identified Lenaldekar (LDK), a compound that eliminates immature T cells in developing zebrafish without affecting the cell cycle in other cell types. LDK is well tolerated in vertebrates and induces long-term remission in adult zebrafish with cMYC-induced T-cell acute lymphoblastic leukemia (T-ALL). LDK causes dephosphorylation of members of the PI3 kinase\/AKT\/mTOR pathway and delays sensitive cells in late mitosis. Among human cancers, LDK selectively affects survival of hematopoietic malignancy lines and primary leukemias, including therapy-refractory B-ALL and chronic myelogenous leukemia samples, and inhibits growth of human T-ALL xenografts. This work demonstrates the utility of our method using zebrafish for antineoplastic candidate drug identification and suggests a new approach for targeted leukemia therapy. Although our efforts focused on leukemia therapy, this screening approach has broad implications as it can be translated to other cancer types involving malignant degeneration of developmentally arrested cells.<\/jats:p>","DOI":"10.1182\/blood-2011-12-398818","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T20:26:17Z","timestamp":1334003177000},"page":"5621-5631","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":133,"title":["Zebrafish screen identifies novel compound with selective toxicity against leukemia"],"prefix":"10.1182","volume":"119","author":[{"given":"Suzanne","family":"Ridges","sequence":"first","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will L.","family":"Heaton","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Eiring","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Batchelor","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Choudhry","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Manos","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sofla","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sanati","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Welborn","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Spangrude","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney R.","family":"Miles","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Cox","sequence":"additional","affiliation":[{"name":"Metabolomics Core Facility, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kimble","family":"Frazer","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"},{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Deininger","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"},{"name":"Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveri","family":"Balan","sequence":"additional","affiliation":[{"name":"Chemistry, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sigman","sequence":"additional","affiliation":[{"name":"Chemistry, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[{"name":"Leukemia and Lymphoma Program, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Perova","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, ON; and"},{"name":"Departments of Medical Biophysics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radia","family":"Johnson","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, ON; and"},{"name":"Immunology, University of Toronto, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Montpellier","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, ON; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Guidos","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, ON; and"},{"name":"Departments of Medical Biophysics and"},{"name":"Immunology, University of Toronto, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus S.","family":"Trede","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute,"},{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111811074748900_B1","unstructured":"National Cancer Institute, Surveillance Epidemiology and End Result\n          Stat Fact Sheets: Leukemia.\n          Accessed December 10, 2011\n          Available at http:\/\/www.seer.cancer.gov\/statfacts\/html\/leuks.html"},{"key":"2019111811074748900_B2","unstructured":"Smith\n              MA\n            \n            \n              Gloeckler Ries\n              LA\n            \n            \n              Gurney\n              JG\n            \n            \n              Ross\n              JA\n            \n          \n          Leukemia. SEER Pediatric Monograph.\n          Accessed December 10, 2011\n          Available at seer.cancer.gov\/publications\/childhood\/leukemia.pdf. National Cancer Institute"},{"issue":"15","key":"2019111811074748900_B3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia.","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"2019111811074748900_B4","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"issue":"26","key":"2019111811074748900_B5","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","article-title":"Molecular genetics of acute lymphoblastic leukemia.","volume":"23","author":"Armstrong","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111811074748900_B6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0037-1963(00)90018-0","article-title":"Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia.","volume":"37","author":"Ferrando","year":"2000","journal-title":"Semin Hematol"},{"issue":"2","key":"2019111811074748900_B7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111811074748900_B8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"issue":"6896","key":"2019111811074748900_B9","first-page":"453","article-title":"Screening for drug discovery: the leading question.","volume":"418","author":"Smith","year":"2002","journal-title":"Nature"},{"issue":"5694","key":"2019111811074748900_B10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"3","key":"2019111811074748900_B11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111811074748900_B12","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1016\/S0960-9822(02)00749-2","article-title":"Notch cleavage: Nicastrin helps Presenilin make the final cut.","volume":"12","author":"Lai","year":"2002","journal-title":"Curr Biol"},{"issue":"8","key":"2019111811074748900_B13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4161\/cc.7.8.5753","article-title":"The role of the PTEN\/AKT Pathway in NOTCH1-induced leukemia.","volume":"7","author":"Palomero","year":"2008","journal-title":"Cell Cycle"},{"issue":"10","key":"2019111811074748900_B14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"2019111811074748900_B15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2009-04-214718","article-title":"Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A\/ARF loss.","volume":"115","author":"Medyouf","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111811074748900_B16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.coph.2008.08.004","article-title":"Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises.","volume":"8","author":"Yap","year":"2008","journal-title":"Curr Opin Pharmacol"},{"issue":"24","key":"2019111811074748900_B17","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1182\/blood-2008-02-136762","article-title":"Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.","volume":"113","author":"Cullion","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111811074748900_B18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dci.2007.11.011","article-title":"Immunology and zebrafish: spawning new models of human disease.","volume":"32","author":"Meeker","year":"2008","journal-title":"Dev Comp Immunol"},{"issue":"10","key":"2019111811074748900_B19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/leu.2009.116","article-title":"Heritable T-cell malignancy models established in a zebrafish phenotypic screen.","volume":"23","author":"Frazer","year":"2009","journal-title":"Leukemia"},{"issue":"5608","key":"2019111811074748900_B20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1126\/science.1080280","article-title":"Myc-induced T cell leukemia in transgenic zebrafish.","volume":"299","author":"Langenau","year":"2003","journal-title":"Science"},{"issue":"19","key":"2019111811074748900_B21","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1073\/pnas.0402248101","article-title":"In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish.","volume":"101","author":"Langenau","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111811074748900_B22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20101691","article-title":"Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.","volume":"208","author":"Gutierrez","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"2019111811074748900_B23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)80086-0","article-title":"Atm-deficient mice: a paradigm of ataxia telangiectasia.","volume":"86","author":"Barlow","year":"1996","journal-title":"Cell"},{"issue":"9","key":"2019111811074748900_B24","first-page":"2527","article-title":"Human myeloid and lymphoid malignancies in the non-obese diabetic\/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.","volume":"60","author":"Fusetti","year":"2000","journal-title":"Cancer Res"},{"issue":"4","key":"2019111811074748900_B25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/leu.2010.323","article-title":"Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.","volume":"25","author":"Masiero","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"2019111811074748900_B26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.191.10.1721","article-title":"Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.","volume":"191","author":"Jones","year":"2000","journal-title":"J Exp Med"},{"issue":"8","key":"2019111811074748900_B27","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/0008-5472.CAN-08-4884","article-title":"Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.","volume":"69","author":"Chiarini","year":"2009","journal-title":"Cancer Res"},{"issue":"5721","key":"2019111811074748900_B28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.1105809","article-title":"Causal protein-signaling networks derived from multiparameter single-cell data.","volume":"308","author":"Sachs","year":"2005","journal-title":"Science"},{"issue":"4","key":"2019111811074748900_B29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1139\/o06-086","article-title":"The relationship between histone H3 phosphorylation and acetylation throughout the mammalian cell cycle.","volume":"84","author":"McManus","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"2019111811074748900_B30","volume-title":"The Cell Cycle","author":"Morgan","year":"2007"},{"issue":"2","key":"2019111811074748900_B31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2007.12.008","article-title":"Critical roles of the PI3K\/Akt signaling pathway in T cell development.","volume":"116","author":"Juntilla","year":"2008","journal-title":"Immunol Lett"},{"issue":"7147","key":"2019111811074748900_B32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"issue":"4","key":"2019111811074748900_B33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nchembio.147","article-title":"Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation.","volume":"5","author":"Yeh","year":"2009","journal-title":"Nat Chem Biol"},{"issue":"7339","key":"2019111811074748900_B34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature09882","article-title":"DHODH modulates transcriptional elongation in the neural crest and melanoma.","volume":"471","author":"White","year":"2011","journal-title":"Nature"},{"issue":"2","key":"2019111811074748900_B35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.008904","article-title":"AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression.","volume":"135","author":"Yeh","year":"2008","journal-title":"Development"},{"issue":"16","key":"2019111811074748900_B36","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1074\/jbc.M109.072744","article-title":"Fas apoptosis inhibitory molecule regulates T cell receptor-mediated apoptosis of thymocytes by modulating Akt activation and Nur77 expression.","volume":"285","author":"Huo","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111811074748900_B37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ceb.2006.04.001","article-title":"Regulating the licensing of DNA replication origins in metazoa.","volume":"18","author":"DePamphilis","year":"2006","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"2019111811074748900_B38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1747-0285.2006.00439.x","article-title":"A chemical genetic screen for cell cycle inhibitors in zebrafish embryos.","volume":"68","author":"Murphey","year":"2006","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"2019111811074748900_B39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nchembio749","article-title":"Small molecules that delay S phase suppress a zebrafish bmyb mutant.","volume":"1","author":"Stern","year":"2005","journal-title":"Nat Chem Biol"},{"issue":"20","key":"2019111811074748900_B40","doi-asserted-by":"crossref","first-page":"19867","DOI":"10.1074\/jbc.M501367200","article-title":"Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.","volume":"280","author":"Feldman","year":"2005","journal-title":"J Biol Chem"},{"issue":"9","key":"2019111811074748900_B41","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.leu.2403044","article-title":"A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.","volume":"17","author":"Martelli","year":"2003","journal-title":"Leukemia"},{"issue":"5","key":"2019111811074748900_B42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma.","volume":"9","author":"Fan","year":"2006","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111811074748900_B43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","article-title":"Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor.","volume":"16","author":"Janes","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"2019111811074748900_B44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","article-title":"PDK1, the master regulator of AGC kinase signal transduction.","volume":"15","author":"Mora","year":"2004","journal-title":"Semin Cell Dev Biol"},{"issue":"5712","key":"2019111811074748900_B45","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex.","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"issue":"19","key":"2019111811074748900_B46","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-08-1385","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.","volume":"68","author":"Serra","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"2019111811074748900_B47","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.76.5.2430","article-title":"Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.","volume":"76","author":"Carson","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7137","key":"2019111811074748900_B48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters.","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"issue":"3","key":"2019111811074748900_B49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.V98.3.834","article-title":"DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase\/Akt signaling pathway.","volume":"98","author":"Henry","year":"2001","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/24\/5621\/1496853\/zh802412005621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/24\/5621\/1496853\/zh802412005621.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:25:34Z","timestamp":1574076334000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/24\/5621\/30296\/Zebrafish-screen-identifies-novel-compound-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,14]]},"references-count":49,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2012,6,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-12-398818","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,14]]}}}